InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by Ozawa Clare, Director. Director active across 2 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 11 disclosures have been logged. Total volume traded: €7.7m. The latest transaction was filed on 6 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
03,573 shares0
Common Stock
SEC:0001209191-22-035067:0·
0200,213 shares0
Common Stock
SEC:0000899243-22-001359·
0200,213 shares0
Common Stock
SEC:0000899243-22-001359:0·
0200,213 shares0
Common Stock
SEC:0000899243-21-049597·
0200,213 shares0
Common Stock
SEC:0000899243-21-049597:0·
€4m303,614 shares@ €12.5993100.0% of flow
Common Stock
SEC:0000899243-21-040771·
€4m303,614 shares@ €12.599350.0% of flow
Common Stock
SEC:0000899243-21-040771:0·
03,466 shares0
Common Stock
SEC:0001209191-21-039351:0·
03,466 shares0
Common Stock
SEC:0001209191-21-039351·
0320,340 shares0
Common Stock
SEC:0000899243-21-019514·
0320,340 shares0
Common Stock
SEC:0000899243-21-019514:0·
11 of 11 declarations
About Ozawa Clare
Clare Ozawa is a Director at Oyster Point Pharma, Inc. In this role, she participates in the governance of the company, providing her expertise in strategy and biopharmaceuticals. Clare plays a key role in the strategic direction of Oyster Point, a company specializing in developing ophthalmic treatments.
